Position
Chief Financial Officer
Company
OnCusp Therapeutics
New YorkBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharmaDescription
OnCusp Therapeutics announced the appointment of Anthony Kim as Chief Financial Officer. Kim brings over 25 years of experience in finance and biotechnology leadership.
Other recent leadership changes in Therapeutics and Pharmaceutical
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Vistagen Appoints Angel S. Angelov as Chief Medical Officer (May 19, 2026)
- TORL BioTherapeutics Appoints Aran Maree, M.D., as Chief Executive Officer (May 7, 2026)
- Retension Pharmaceuticals Appoints Alison Schecter as Chief Medical Officer and Alex Schwartz as Chief Financial Officer (May 27, 2026)
- BridgeBio Oncology Therapeutics Appoints Pedro J. Beltran as CEO and Idan Elmelech as COO (April 22, 2026)
- Poxel Appoints Yves Decadt as Chief Executive Officer (June 10, 2026)
- NRx Pharmaceuticals Appoints Glenn Tyson as Chief Commercial Officer (April 13, 2026)
Who to call at OnCusp Therapeutics, and when
A new leader at OnCusp Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day OnCusp Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at OnCusp Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at OnCusp Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment OnCusp Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
OnCusp Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.